Mansonella

Mansonella infections occur in parts of Africa, Latin America, and the Caribbean. Many cause no symptoms. When symptoms occur, itching, rashes, swelling, and other nonspecific complaints can overlap with those of other infections acquired in the same regions.

This test looks for Mansonella DNA in stool using qPCR. Its clinical utility has not been established. The cited studies do not establish its diagnostic accuracy, a benefit from screening, or its usefulness for monitoring treatment. Evidence supporting blood or skin testing cannot establish the performance of this stool assay.

Where the Worms Live

An infected biting midge or, for some Mansonella ozzardi infections, a blackfly deposits larvae on your skin during a blood meal. The larvae enter through the bite wound and develop into adult worms. Their location depends on the species.

Microfilariae are the worms' microscopic offspring. Mansonella perstans adults live mainly in body cavities and release microfilariae into blood. Mansonella ozzardi microfilariae are also usually found in blood. Mansonella streptocerca adults and microfilariae live in the skin. This difference determines which specimen is useful for diagnosis.

Species identification is still developing. Genetic studies support treating Mansonella sp. "DEUX" as a species distinct from M. perstans. In a blood-based survey of 834 people in Gabon, it was the most frequently detected filarial species. Based on sequence analysis, some published assays designed specifically for M. perstans were predicted not to detect it. A test labeled "Mansonella" should not be assumed to detect every species.

What the Human Stool Study Found

A Cameroon study examined stool from 52 people recruited with M. perstans and/or Loa loa infection. PCR detected no filarial DNA in any stool sample. This was a mixed group of infections, not 52 confirmed Mansonella cases, and some participants also carried common intestinal worms.

The study used PCR methods that differ from this test's qPCR, so it does not provide a detection rate for this assay. It does show why a negative stool result cannot be used to exclude a blood-dwelling filarial infection.

The researchers proposed that intestinal bleeding might allow filarial DNA to enter stool, but they did not establish that mechanism. A positive stool finding does not by itself demonstrate gut bleeding or another intestinal infection.

What qPCR Measures

qPCR copies selected DNA sequences and monitors the signal as they accumulate. With suitable calibration, it can estimate the amount of target DNA. The method name alone does not tell you whether this laboratory reports a detected/not-detected result or a numerical quantity.

The test information available for review does not provide reporting units, gene targets, species coverage, or a validated relationship between stool DNA and the number of worms in your body. A numerical result, if supplied, should not be interpreted as infection severity or compared directly with blood measurements.

What Blood and Skin Studies Show

Microscopy can identify M. perstans and M. ozzardi microfilariae in blood and M. streptocerca microfilariae in skin snips. Molecular methods can detect additional infections, although performance depends on the assay, species, sample volume, and processing. Some blood qPCR assays have also missed infections found by microscopy.

These findings support attention to specimen choice. They do not validate stool qPCR, and a negative blood result cannot exclude a species that lives primarily in skin.

Itching and Hives

In the Gabon skin-snip survey, M. streptocerca infection was associated with more frequent hives, male sex, and poorer housing conditions after adjustment. The study assessed infection and symptoms at one point in time, so it could not establish that the parasite caused the hives. These findings concern skin infection, not Mansonella DNA detected in stool.

Malaria in Children Born to Infected Mothers

A Ugandan birth cohort recorded 2,345 live births and followed children for up to five years. Maternal M. perstans infection was identified through blood testing during pregnancy. Children of infected mothers had about a fifth higher rate of clinical malaria after adjustment for measured confounders.

This was an observational association. It did not show that treating maternal Mansonella infection prevents childhood malaria or establish a benefit from screening during pregnancy. Stool qPCR was not evaluated.

Nodding Syndrome in South Sudan

Nodding syndrome is a seizure disorder affecting children in parts of East Africa. A case-control study compared 72 affected children with 109 controls. M. perstans DNA detected in plasma was associated with about seven times the odds of the syndrome in a multivariable analysis, but the estimate was imprecise.

Several infectious and nutritional findings were associated with the syndrome. The study did not establish its cause. A separate case-control study in Mahenge, Tanzania found no M. perstans infections in cases or controls and instead linked nodding syndrome to exposure to Onchocerca volvulus, the worm that causes river blindness. Neither study makes a stool result a predictor of seizures.

Infection Can Be Present Without Clear Symptoms

On Bioko Island, researchers detected M. perstans DNA in blood retained on used malaria test strips from people who were mostly without fever. Detection was more frequent in older people and in households of lower socioeconomic status, with differences by sex and location. These blood-based findings describe local patterns of infection.

In the Colombian Amazon, a DNA amplification method applied to whole blood detected substantially more M. ozzardi infections than blood-smear microscopy or the same molecular method applied to plasma. Whole blood and plasma therefore cannot be assumed to give equivalent results, even before considering the much larger difference between blood and stool.

A European series of 392 imported M. perstans cases found that symptoms and supporting laboratory findings varied. Eosinophils were elevated in about two thirds of patients whose eosinophil results were available. Eosinophils are white blood cells that can increase with worm infections, allergies, and several other conditions. Their absence does not exclude infection, and an increase does not identify its cause.

When Results Can Be Misleading

• Specimen mismatch: stool may contain no detectable target DNA despite an infection elsewhere in the body. The clinical sensitivity of this stool qPCR assay has not been established by the cited studies.
• Incomplete species coverage: the assay's DNA targets determine which Mansonella species it can detect. A broad test name does not establish broad coverage.
• Extraction failure or inhibition: stool contains substances that can interfere with DNA amplification. Appropriate laboratory controls are needed to distinguish a valid negative result from an unsuccessful reaction.
• Contamination or unintended amplification: a positive signal requires evidence that the assay distinguishes its intended target from other organisms and that contamination controls passed. These characteristics cannot be inferred from the word qPCR.
• Overinterpreting a quantity: DNA abundance in stool has no established relationship to total worm burden or symptom severity. Amplification-cycle values and quantities from different assays are not interchangeable.
• Equating DNA with living worms: a DNA signal alone does not establish parasite viability. The behavior of this stool result after treatment has not been validated.